Back
Caribou Biosciences Vs. Lexicon Pharmaceuticals Industry Stock Comparison
Buy
67
CRBU
Caribou Biosciences
Last Price:
2.20
Seasonality Move:
-3.22%
Sell
20
LXRX
Lexicon Pharmaceuticals
Last Price:
1.09
Seasonality Move:
22.89%
Buy
67
Caribou Biosciences (CRBU)
is a Buy
Is Caribou Biosciences a Buy, Sell or Hold?
- The current Caribou Biosciences [CRBU] share price is $2.35. The Score for CRBU is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- CRBU is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
20
Lexicon Pharmaceuticals (LXRX)
is a Sell
Is Lexicon Pharmaceuticals a Buy, Sell or Hold?
- The current Lexicon Pharmaceuticals [LXRX] share price is $1.19. The Score for LXRX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- LXRX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
CRBU Stock Price Chart
What is Caribou Biosciences's stock price today?
-
The Caribou Biosciences share price today is $2.35
The current trend is moderately bearish and CRBU is experiencing selling pressure, which indicates risk of future bearish movement.
LXRX Stock Price Chart
What is Lexicon Pharmaceuticals's stock price today?
-
The Lexicon Pharmaceuticals share price today is $1.19
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LXRX is experiencing selling pressure, which indicates risk of future bearish movement.
CRBU Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.19 | Buy |
| Relative Strength Index (14 RSI): | 54.29 | Buy |
| Chaikin Money Flow: | -1507543 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.79 - 2.45) | Buy |
| Bollinger Bands (100): | (1.76 - 2.32) | Buy |
LXRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 31.68 | Sell |
| Chaikin Money Flow: | -2399945 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.34 - 1.96) | Sell |
| Bollinger Bands (100): | (1.49 - 1.99) | Sell |
CRBU Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.56 | Sell |
| 20-day SMA: | 2.18 | Buy |
| 50-day SMA: | 2.03 | Buy |
| 200-day SMA: | 3.35 | Sell |
| 8-day EMA: | 2.5 | Sell |
| 20-day EMA: | 2.28 | Buy |
| 50-day EMA: | 2.14 | Buy |
| 200-day EMA: | 3.04 | Sell |
LXRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.23 | Sell |
| 20-day SMA: | 1.64 | Sell |
| 50-day SMA: | 1.64 | Sell |
| 200-day SMA: | 1.9 | Sell |
| 8-day EMA: | 1.33 | Sell |
| 20-day EMA: | 1.51 | Sell |
| 50-day EMA: | 1.63 | Sell |
| 200-day EMA: | 1.77 | Sell |
Caribou Biosciences Earnings Growth & CRBU Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.50 per share.
Lexicon Pharmaceuticals Earnings Growth & LXRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.09 per share.
Caribou Biosciences Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lexicon Pharmaceuticals Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||